Abstract
A photoluminescent probe for the determination of captopril is proposed based on the enhancement of luminescence from 2-mercaptopropionic modified CdTe quantum dots (2-MPA-CdTe QDs). Under optimum conditions, the calibration model (the Langmuir binding isotherm) was linear up to 4.8 × 10−4 mol L−1 with equilibrium binding constant of 3.2 × 104 L mol−1 and limit of detection (xb + 3 sb) of 2.7 × 10−7 mol L−1 (59 ng mL−1). The approach was tested in the determination of captopril in pharmaceutical formulations and the results were in agreement with the ones obtained using reference method. The possible mechanism of interaction is also investigated by Raman and electronic absorption spectroscopy and dynamic light scattering.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
More From: Materials Research Express
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.